Safety and Therapeutic Potential of the FDA-approved Drug Metformin for C9orf72 ALS/FTD

Clinical trial NCT04220021 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04220021
Sponsor: University of Florida
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

C9orf72 Amyotrophic Lateral Sclerosis (ALS)Frontotemporal Dementia

Start date: 2020-01-10
Primary completion: 2024-08-26
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.